Search research articles
Contact Us
Filters
Showing results (31-40 of 120) with videos related to
Page
of 12
Sort By:
American Journal of Clinical Pathology
|
April 15, 2004
Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients
Rina Kansal, George Deeb, Maurice Barcos, et al.
Leukemia Research
|
August 14, 2012
Synergism between clofarabine and decitabine through p53R2: a pharmacodynamic drug-drug interaction modeling
Karen E Thudium, Sampa Ghoshal, Gerald J Fetterly, et al.
Expert Opinion on Orphan Drugs
|
August 8, 2019
Bosutinib for the Treatment of Philadelphia Chromosome-Positive Leukemias
Cristina Varallo-Rodriguez, Craig W Freyer, Evelena P Ontiveros, et al.
Cancer Genetics and Cytogenetics
|
April 22, 2009
Acute myeloid leukemia and diabetes insipidus with monosomy 7
Antoine Harb, Wei Tan, Gregory E Wilding, et al.
Cancer Immunology, Immunotherapy : CII
|
July 13, 2005
T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expression
Jonathan A Claus, Michael T Brady, Jaewoo Lee, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 28, 2011
Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population
Anthony Jarkowski, Alan Forrest, Richard P Sweeney, et al.
Blood
|
January 5, 2002
Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
Mustafa Benekli, Zheng Xia, Kathleen A Donohue, et al.
Leukemia & Lymphoma
|
March 22, 2014
Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors
H Jean Khoury, Jorge Cortes, Michele Baccarani, et al.
Leukemia Research
|
May 6, 2021
A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia
Pankit Vachhani, Jeffrey Baron, Craig W Freyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2013
Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models
Scott Portwood, Deepika Lal, Yung-Chun Hsu, et al.
Page
of 12
Search research articles
Search
Showing results (31-40 of 120) with videos related to
Sort By:
Page
of 12
American Journal of Clinical Pathology
|
April 15, 2004
Precursor B lymphoblastic leukemia with surface light chain immunoglobulin restriction: a report of 15 patients
Rina Kansal, George Deeb, Maurice Barcos, et al.
Leukemia Research
|
August 14, 2012
Synergism between clofarabine and decitabine through p53R2: a pharmacodynamic drug-drug interaction modeling
Karen E Thudium, Sampa Ghoshal, Gerald J Fetterly, et al.
Expert Opinion on Orphan Drugs
|
August 8, 2019
Bosutinib for the Treatment of Philadelphia Chromosome-Positive Leukemias
Cristina Varallo-Rodriguez, Craig W Freyer, Evelena P Ontiveros, et al.
Cancer Genetics and Cytogenetics
|
April 22, 2009
Acute myeloid leukemia and diabetes insipidus with monosomy 7
Antoine Harb, Wei Tan, Gregory E Wilding, et al.
Cancer Immunology, Immunotherapy : CII
|
July 13, 2005
T-Cell activation by t(9;22) acute lymphoblastic leukemia-derived dendritic-like cells is associated with increased tapasin expression
Jonathan A Claus, Michael T Brady, Jaewoo Lee, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
April 28, 2011
Characterization of vancomycin pharmacokinetics in the adult acute myeloid leukemia population
Anthony Jarkowski, Alan Forrest, Richard P Sweeney, et al.
Blood
|
January 5, 2002
Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival
Mustafa Benekli, Zheng Xia, Kathleen A Donohue, et al.
Leukemia & Lymphoma
|
March 22, 2014
Omacetaxine mepesuccinate in patients with advanced chronic myeloid leukemia with resistance or intolerance to tyrosine kinase inhibitors
H Jean Khoury, Jorge Cortes, Michele Baccarani, et al.
Leukemia Research
|
May 6, 2021
A phase 2 trial of single low doses of rasburicase for treatment of hyperuricemia in adult patients with acute leukemia
Pankit Vachhani, Jeffrey Baron, Craig W Freyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 4, 2013
Activity of the hypoxia-activated prodrug, TH-302, in preclinical human acute myeloid leukemia models
Scott Portwood, Deepika Lal, Yung-Chun Hsu, et al.
Page
of 12